Cargando…
Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC), an advanced liver cancer, has poor prognosis and limited treatment options. Tumor Treating Fields (TTFields) therapy is a novel antimitotic treatment, delivering electric fields that induce death and inhibit replication of cancer cells. We aimed to det...
Autores principales: | Davidi, Shiri, Jacobovitch, Sara, Shteingauz, Anna, Martinez-Conde, Antonia, Braten, Ori, Tempel-Brami, Catherine, Zeevi, Einav, Frechtel-Gerzi, Roni, Ene, Hila, Dor-On, Eyal, Voloshin, Tali, Tzchori, Itai, Haber, Adi, Giladi, Moshe, Kinzel, Adrian, Weinberg, Uri, Palti, Yoram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220990/ https://www.ncbi.nlm.nih.gov/pubmed/35740624 http://dx.doi.org/10.3390/cancers14122959 |
Ejemplares similares
-
Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959
por: Davidi, Shiri, et al.
Publicado: (2023) -
Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
por: Voloshin, Tali, et al.
Publicado: (2020) -
In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso
por: Blatt, Roni, et al.
Publicado: (2021) -
AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
por: Shteingauz, Anna, et al.
Publicado: (2018) -
Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines
por: Fishman, Hila, et al.
Publicado: (2023)